CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy. - Wikidata - wikimedia - TriplyDB

CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.

CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.

http://www.wikidata.org/entity/Q40532397

about

Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary New challenges in therapeutic vaccines against HIV infection.On the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection.Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.Virus-Host Gene Interactions Define HIV-1 Disease Progression.Tackling HIV and AIDS: contributions by non-human primate models.T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.Highlights from the Third Biennial Strategies for an HIV Cure Meeting: 14-16 November 2016, Bethesda, MD, USA.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay.Wake me up before you go: A strategy to reduce the latent HIV reservoir.A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study.Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.Recent progress in understanding HIV reservoirs.ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir.Immune Interventions to Eliminate the HIV Reservoir.Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection.The B-Cell Follicle in HIV Infection: Barrier to a Cure.Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA.The dynamics of SIV 2-LTR Circles in the Presence and Absence of CD8+ Cells.Intragastric administration of Lactobacillus plantarum and AT-2-inactivated SIV does not protect Indian rhesus macaques from intra-rectal SIV challenge nor reduce virus replication after transmission.Short-term pIFN-α2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques.Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review.Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.Tfh1 Cells in Germinal Centers During Chronic HIV/SIV Infection.Differentiation and Function of Follicular CD8 T Cells During Human Immunodeficiency Virus Infection.Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals CD8+ lymphocyte control of SIV infection during antiretroviral therapy Phenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV

P2860

Q33742139-2C4AA70F-34B4-4A0B-A7F8-11C9E63BD181 Q38692205-8157E6C3-AA19-4156-82E6-330BEF19A753 Q38692324-09E24A06-39CE-4485-BEE2-0344AD4AA0F7 Q38839394-53C6C933-3D67-4C80-9D75-1370229430E0 Q39315707-78F197D6-55C1-4EDF-AD6C-C0DD7B7E968B Q39362365-8E8DAD56-95F9-4991-931B-FC3556D43570 Q39400038-1779AEF8-76AF-4EFE-81E2-4904221DE265 Q40191155-0F40786F-4716-437E-9D82-10C60DF9D268 Q41933638-BCC6BDB2-7A5E-4FC8-B80D-66237A7A9B6D Q42318283-D55FF525-E441-4164-A0B6-3C5732D9F0E6 Q45326424-CD4B26BD-C60E-46A0-ABE8-3107F0C9458C Q45349979-D3116F19-D14C-4394-967D-D6BAC5E88DEE Q45874441-6DB1DB22-183F-43B9-ADD9-2F82499D2CD1 Q47096232-604ED681-D7AA-4D87-A87D-3E0103E2A05B Q47550536-D47AB5F0-E130-4E61-BD9B-5298D3025553 Q47566696-CCCF3AC7-B228-4BA9-9D51-BFF08B6BCE1E Q47585968-38B336BA-8880-4AD4-B26B-32A1C0D96927 Q47600020-D9F4CFE7-32C8-4478-9356-82023D01E713 Q47600062-61B1583F-B232-4F84-990A-417603C05465 Q48204920-31303C7D-5E15-404C-BDB2-F7581B1F92DF Q48505361-9A74D1ED-0316-4BE6-A36E-4F4165F6FF07 Q52571192-277F5406-B9F4-470E-9F1A-CD06102BA363 Q52593219-44A335EB-82C7-464A-A944-E2A3EA17AF7E Q52680808-D72117DD-7893-4449-A5A1-18A8EF4C41E1 Q54222562-0581EE02-8190-45C3-8015-7FBA354F135A Q54942553-27ED81F9-6FAB-4567-8689-70F5EDA925FE Q55048177-172B5F9B-DEFD-4D53-BC84-74ACE30C4F85 Q55187093-8002ABEA-F6CF-4F22-814F-5085415B9272 Q55365295-2206C2AD-D47A-4497-829A-C053D7754D84 Q56918262-349AB818-36C5-4433-B009-1071A51CD94E Q57039737-56B270B1-62E8-44B9-9C44-8E2EE36226E1 Q57281967-B10963BA-711F-42E4-9A39-B82F52190098 Q58572549-71A5C3D7-A2BD-4296-8B2D-571833B36563 Q59125545-60D8A87F-E497-48E3-8C5F-5E7E363E52F6

P2860

CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.

http://www.wikidata.org/entity/Q40532397

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

CD8(+) Lymphocytes Are Require ...... t-Term Antiretroviral Therapy.

@en

type

label

CD8(+) Lymphocytes Are Require ...... t-Term Antiretroviral Therapy.

@en

prefLabel

CD8(+) Lymphocytes Are Require ...... t-Term Antiretroviral Therapy.

@en

P1433

Q40532397-A4A37A21-99EA-4932-A018-79A10BE6FCA2

P1476

Q40532397-8FB412E6-2B7C-4B93-B59E-181E5FE80DA0

P2093

Q40532397-0DDC5373-D411-4E8A-A788-5EC4ED4BE1E3

Q40532397-1394D1CA-53B4-4DD3-8CA6-B189A0834F6D

Q40532397-1611F5DE-0CEC-4000-8A86-3B3BC1B69FE3

Q40532397-2BA862DE-7579-4533-ADAC-814071755E9A

Q40532397-39A873B0-089F-4C8C-B91E-50BA8FD966DF

Q40532397-5B3824FD-2C6C-40F6-A099-21BB6250BD1C

Q40532397-5CAF46DC-F822-49C0-99DF-E5583D3F782B

Q40532397-63860197-9209-4FE2-8B79-ADCCEAEDB286

Q40532397-837E8976-3210-4228-BD78-A2D60D1401EA

Q40532397-9D12F580-167D-450F-933C-3D3123B20DD7

P2860

Q40532397-00425907-09A1-4947-AB52-FE7838C20F73

Q40532397-029847C7-F9D8-4753-BA24-0EBFB89E9856

Q40532397-0749CFB7-51B5-460E-87D5-56EFD9EAAAE6

Q40532397-0D33D5FA-D584-43C2-9DA6-B890FBF50B53

Q40532397-185966C6-E0E9-4EA8-B1CE-F69E7C29827E

Q40532397-19BDCF92-4075-4CCB-9CEF-758269B893A1

Q40532397-20656C62-9573-44C0-B024-F2A1057FC506

Q40532397-219F2E0A-64EB-4311-A7B0-99467276E037

Q40532397-3107D553-49FE-4A02-BEA2-44F6ECD20CBD

Q40532397-32022D96-AAA6-4953-B086-22EA0BFF3E2F

P304

Q40532397-8AA085F4-C398-488C-BA3A-5CF7C5156259

P31

Q40532397-576F0DBA-DC16-4D52-A65D-A6DED41403D1

P356

Q40532397-16AD4EDB-3811-4754-9ADE-C254ED6358A3

P407

Q40532397-9854951B-1721-4C8A-AE1F-8DBABAD92A55

P433

Q40532397-A5F51ED5-10D9-4E88-9202-30A40E9483DB

P478

Q40532397-1FC41238-6687-4A2E-BFD9-6F3A5A7BEB89

P50

Q40532397-139E3D50-9D16-4509-9ED2-D105510C09C6

Q40532397-F6E01BD7-28DE-4504-8AFF-18B2DEC1A670

P577

Q40532397-718A875B-70E3-4948-9B21-FE19240E87E6

P698

Q40532397-22AEBB59-A8CD-451E-9666-ED90F0BADA81

P921

Q40532397-BD04DAB4-C196-4977-9A41-C3D6EF866EB0

P932

Q40532397-5DE87879-00FA-45D9-9731-69B67AE7600C

P356

J.IMMUNI.2016.08.018

P1433

P1476

CD8(+) Lymphocytes Are Require ...... rt-Term Antiretroviral Therapy

@en

P2093

Ann Chahroudi

http://www.w3.org/2001/XMLSchema#string

Benton O Lawson

http://www.w3.org/2001/XMLSchema#string

Cynthia A Derdeyn

http://www.w3.org/2001/XMLSchema#string

David Lee

http://www.w3.org/2001/XMLSchema#string

Emily K Cartwright

http://www.w3.org/2001/XMLSchema#string

Guido Silvestri

http://www.w3.org/2001/XMLSchema#string

Jacob D Estes

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Lifson

http://www.w3.org/2001/XMLSchema#string

Lori Spicer

http://www.w3.org/2001/XMLSchema#string

Melon Nega

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission

Viral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaques

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A

Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

P304

656-668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2016.08.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Joern E Schmitz

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27653601

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5087330

http://www.w3.org/2001/XMLSchema#string